The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites.

[1]  R. Blakely,et al.  Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants* , 2006, Journal of Biological Chemistry.

[2]  Denis Guilloteau,et al.  [11C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET , 2005, Synapse.

[3]  C. Halldin,et al.  Quantification of 11C-MADAM binding to the serotonin transporter in the human brain. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  O. Wiborg,et al.  High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions , 2005, Neuroscience Letters.

[5]  Yiyun Huang,et al.  Serotonin Transporter Availability in Patients with Schizophrenia: A Positron Emission Tomography Imaging Study with [11C]DASB , 2005, Biological Psychiatry.

[6]  Bengt Långström,et al.  Potential of [11C]DASB for measuring endogenous serotonin with PET: binding studies. , 2005, Nuclear medicine and biology.

[7]  Fenghua Chen,et al.  Characterization of an allosteric citalopram‐binding site at the serotonin transporter , 2005, Journal of neurochemistry.

[8]  Ove Wiborg,et al.  The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors , 2003, European Neuropsychopharmacology.

[9]  K. Bogeso,et al.  The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer , 2005, Journal of Neural Transmission / General Section JNT.

[10]  Sylvain Houle,et al.  Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. , 2004, Archives of general psychiatry.

[11]  Marie-José Bélanger,et al.  Biodistribution and radiation dosimetry of [11C]DASB in baboons. , 2004, Nuclear medicine and biology.

[12]  U. Müller,et al.  Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders , 2004, Neuroscience & Biobehavioral Reviews.

[13]  A. Heinz,et al.  DASB –in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as positron emission tomography (PET) tracer , 2004, Journal of neurochemistry.

[14]  C. Halldin,et al.  Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain , 2004, Human brain mapping.

[15]  K. Bogeso,et al.  Escitalopram versus citalopram: the surprising role of the R-enantiomer , 2004, Psychopharmacology.

[16]  Sylvain Houle,et al.  Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. , 2004, The American journal of psychiatry.

[17]  Mark Slifstein,et al.  Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  C. Halldin,et al.  Selectivity of 3H‐MADAM binding to 5‐hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects , 2004, British journal of pharmacology.

[19]  D. Murphy,et al.  Pharmacological and Genetic Characterization of Two Selective Serotonin Transporter Ligands: 2-[2-(Dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-Amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB) , 2004, Journal of Pharmacology and Experimental Therapeutics.

[20]  Denis Guilloteau,et al.  Pharmacological Characterization ofN,N-Dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a Ligand of the Serotonin Transporter with High Affinity and Selectivity , 2003, Journal of Pharmacology and Experimental Therapeutics.

[21]  Alan A. Wilson,et al.  Comparative Evaluation in Nonhuman Primates of Five PET Radiotracers for Imaging the Serotonin Transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  Sylvain Houle,et al.  In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography. , 2002, Nuclear medicine and biology.

[23]  Alan A. Wilson,et al.  Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. , 2001, The American journal of psychiatry.

[24]  R. De La Garza,et al.  Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. , 2001, Brain research. Molecular brain research.

[25]  S. Houle,et al.  Novel Radiotracers for Imaging the Serotonin Transporter by Positron Emission Tomography: Synthesis, Radiosynthesis, and in Vitro and ex Vivo Evaluation of (11)C-Labeled 2-(Phenylthio)araalkylamines. , 2000, Journal of medicinal chemistry.

[26]  Alan A. Wilson,et al.  Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.

[27]  C. Sánchez,et al.  The antidepressant effects of citalopram are mediated by the S-(+)- and not the R(−)-enantiomer , 1999, European Neuropsychopharmacology.

[28]  M. Nader,et al.  Distribution of [3H]Citalopram Binding Sites in the Nonhuman Primate Brain , 1999, Annals of the New York Academy of Sciences.

[29]  L. Descarries,et al.  Validation of the transporter ligand cyanoimipramine as a marker of serotonin innervation density in brain. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  M. Kuhar,et al.  Development of PET/SPECT ligands for the serotonin transporter. , 1994, NIDA research monograph.

[31]  C. Bench,et al.  Evaluation of S-[11C]citalopram as a radioligand for in vivo labelling of 5-hydroxytryptamine uptake sites. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[32]  T. Reader,et al.  [3H]Paroxetine Binding and Serotonin Content of Rat Cortical Areas, Hippocampus, Neostriatum, Ventral Mesencephalic Tegmentum, and Midbrain Raphe Nuclei Region Following p‐Chlorophenylalanine and p‐Chloroamphetamine Treatment , 1992, Journal of neurochemistry.

[33]  L. Descarries,et al.  [3H]Paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region , 1991, Synapse.

[34]  S. Snyder,et al.  Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. , 1987, The Journal of pharmacology and experimental therapeutics.